All Articles

China's energy giant uses a five-country open day to showcase green tech, but its strategy reveals a complex mix of education, soft power, and a debated energy portfolio.

A new partnership aims to solve enterprise AI's biggest hurdle: deploying governed systems in industries where compliance is non-negotiable.

A plant-based bomber jacket is hitting the mainstream. Is this the blueprint for fashion's sustainable future or just another high-profile experiment?

A breakthrough system grows larger, more complex human gut tissues twice as fast, promising to revolutionize drug testing and regenerative medicine.

A revolutionary single-dose, over-the-counter cold sore tablet launches in Europe, promising new convenience for millions and shaking up the self-care market.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

A Fresno firm is challenging traditional retirement planning by putting personal goals first, aiming for more meaningful and financially secure futures.

Purecore Metals launches a major exploration program for critical minerals in BC while committing heavily to market-making and investor awareness.

A North Carolina firm is tackling the two biggest threats to retirement security: soaring healthcare costs and taxes. Here's how their tech-driven plan works.

FortuneX Acquisition Corp. raised $75M in its IPO, but it enters a SPAC market wary of past failures and facing stricter regulatory oversight.

Starlight Capital's new offering provides investors a 6.85% yield, tapping into demand for real assets while funding a strategic reorganization.

South Korea's KT SAT pivots from satellite operator to a 'Total Space Solution Provider,' integrating networks to chase sovereign security and universal access.

Pliant Therapeutics heads to ASCO with data on a novel drug designed to reawaken the immune system's attack on advanced, treatment-resistant tumors.

New data shows Moleculin Biotech's Annamycin avoids heart toxicity, a breakthrough that could transform treatment for leukemia and sarcoma patients.

South Korean food leader Binggrae uses THAIFEX 2026 to launch a strategic assault on Southeast Asia with localized flavors and a diversified portfolio.

A wave of severe storms has forced homeowners to replace aging roofs, revealing a hidden crisis of deferred maintenance and overwhelming local contractors.

A Singaporean group just bought a century-old Milanese tailor. Can 3D scanning and global ambition coexist with a legacy built on the motto 'Never bend'?

A new partnership between Riverchain and Micro Connect uses AI and a novel funding model to inject vital capital into Hong Kong's construction industry.

Quanex will report Q2 results on June 4, with investors watching for updates on its Tyman integration and performance in a tough building market.